Evofem Biosciences, Inc.
OTC:EVFM
0.07 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| 52.979 | -76.698 | -205.192 | -142.309 | -80.033 | -125.712 | -9.993 | -13.019 | -43.157 | -10.819 | -15.016 | -7.828 |
| Depreciation & Amortization
| 1.781 | 1.015 | 1.023 | 0.302 | 0.263 | 0.262 | 0.046 | 0.069 | 0.058 | 0.018 | 0.072 | 0.124 |
| Deferred Income Tax
| 0 | 0 | 33.957 | 36.768 | 28.125 | 0 | 0 | 0.005 | 0.006 | 0.861 | 0.538 | 1.152 |
| Stock Based Compensation
| 1.189 | 3.313 | 8.898 | 12.697 | 8.579 | 17.842 | 0.759 | 1.083 | 1.578 | 0.613 | 0.08 | 0.122 |
| Change In Working Capital
| 4.728 | 6.018 | 10.578 | -15.227 | -12.673 | 3.058 | 0.931 | -4.494 | 3.382 | -0.329 | 1.394 | -1.839 |
| Accounts Receivables
| -4.612 | 5.323 | -5.382 | -1.067 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 2.106 | 1.566 | -0.021 | -6.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 4.09 | 4.474 | -0.004 | 4.126 | -2.931 | 3.799 | 0.51 | -5.441 | 4.434 | 0.455 | 0.051 | -0.493 |
| Other Working Capital
| 3.144 | -5.345 | 15.985 | -12.276 | -9.742 | -0.741 | 0.421 | 0.947 | -1.051 | -0.784 | 1.343 | -1.346 |
| Other Non Cash Items
| -66.478 | -4.058 | 4.069 | 2.94 | 0.642 | 48.05 | 0.056 | 0.1 | 0.22 | 0.084 | 0.027 | 0.873 |
| Operating Cash Flow
| -8.968 | -70.41 | -146.667 | -104.829 | -55.097 | -56.5 | -8.201 | -16.255 | -37.911 | -9.572 | -12.904 | -7.396 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -0.004 | -0.341 | -2.939 | -2.254 | -0.164 | -0.007 | -0.006 | -0.498 | -0.226 | -0.018 | -0.021 | 0 |
| Acquisitions Net
| 0 | 0 | 0.25 | 0.25 | 0.25 | 2.15 | 0.25 | 0.003 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | -0.25 | -8.233 | 0 | 0 | 0 | -0.2 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 8.233 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0.25 | 0.25 | 0.032 | 0.25 | 0.007 | 0.003 | -0.2 | 0 | 0.104 | 0 |
| Investing Cash Flow
| -0.004 | -0.341 | -2.689 | 6.229 | -8.115 | 2.143 | 0.007 | 0.003 | -0.426 | -0.018 | 0.083 | 0 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -4.486 | -5.608 | 0 | -50 | -4.01 | 0 | -9.925 | -10.052 | 0 | -0.21 | -0.448 | -0.824 |
| Common Stock Issued
| 0.29 | 57.551 | 81.534 | 107.968 | 78.36 | 56.166 | -0.713 | 0.034 | 0.139 | 57.815 | 0 | 0.015 |
| Common Stock Repurchased
| 0 | -0.018 | -0.327 | -2.869 | 75.4 | -1.592 | 0 | 0 | 42.126 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | -0.157 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.29 | -0.018 | 9.486 | 157.095 | 3.726 | 56.166 | 0.026 | 0.034 | -41.987 | 23.568 | 6.533 | 13.476 |
| Financing Cash Flow
| 4.776 | 63.141 | 90.693 | 154.226 | 78.076 | 54.417 | 0.026 | -10.019 | 0.139 | 81.174 | 6.085 | 12.667 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -3.396 | -8.812 | -58.663 | 55.626 | 14.864 | 0.06 | -8.168 | -26.271 | -38.199 | 71.584 | -6.736 | 5.271 |
| Cash At End Of Period
| 0.58 | 4.776 | 13.588 | 72.251 | 16.625 | 1.761 | 3.51 | 11.478 | 37.749 | 75.948 | 4.364 | 11.1 |